Shelter Pharma Ltd - 543963 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Certificate under regulation 40(9) of LODR 201517-04-2024
Shelter Pharma Ltd - 543963 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Certificate under regulation 40(9) of LODR 2015Shelter Pharma Ltd - 543963 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate for Non-Applicability of Regulation 74(5) of SEBI(DP) Regulation 2018Shelter Pharma Ltd - 543963 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Certificate regarding non applicability of Regulation 24A LODR 2015Shelter Pharma Ltd - 543963 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Certificate under Regulation 74(5) of SEBI (DP) Regulation, 2018 for quarter ended 31st December, 2023Shelter Pharma Ltd - 543963 - Clarification Sought By BSE Limited ('BSE') For Significant Increase In Price/Movement Of Securities Of The Company
With reference to clarification sought from company in relation to increase/spurt in price/volume of the securities of the company , clarification is attached herewithShelter Pharma Ltd - 543963 - Clarification sought from Shelter Pharma Ltd
The Exchange has sought clarification from Shelter Pharma Ltd on January 11, 2024 with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.The reply is awaited.Shelter Pharma Ltd - 543963 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order
Shelter Pharma Limited has secured a noteworthy order from Taha Drugs & Chemicals co. Ltd - Sudan, for All vitamin Tablets Nutraceuticals and Joemega Capsules Nutraceuticals worth Rupees 1 crore ( Approx)Shelter Pharma Ltd - 543963 - Non-Applicability Of Regulation 23(9) As Per Regulation 15 Of Chapter IV Of SEBI (LODR) Regulations, 2015 For The Half Year Ended September-2023
Declaration regarding Non applicability of Regulation 23(9) of SEBI(LODR) Regulation 2015Shelter Pharma Ltd - 543963 - Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015 Regarding Appointment Of CA Mohammadaltaf Rasulbhai Sachora (ALTAF SACHORA & CO), FRN NO: 138017W Chartered Accountants As Internal Auditor.
Appointment of Internal Auditor For Financial year 2023-2024